TBPH — Theravance Biopharma, Inc. | XLV Holdings | StockAdder

(TBPH)

Theravance Biopharma, Inc.

Live chart and latest TBPH stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

TBPH News

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Mar 19, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Theravance Biopharma (TBPH)

Apr 8, 2026 Stock Titan

Theravance Biopharma (TBPH) CEO awarded 75,000 Ordinary Shares

Apr 3, 2026 Finviz

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)

Mar 9, 2026 Stock Traders Daily

How Theravance Biopharma Inc. (TBPH) Affects Rotational Strategy Timing

Apr 1, 2026 Zacks Investment Research

Is the Options Market Predicting a Spike in Theravance Biopharma Stock?

Jan 28, 2026 ChartMill

Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum

Feb 11, 2026 simplywall.st

Revenues Not Telling The Story For Theravance Biopharma, Inc. (NASDAQ:TBPH) After Shares Rise 32%

Nov 12, 2025 Seeking Alpha

Theravance stock in focus after trial setback (TBPH:NASDAQ)

Mar 3, 2026 TradingView — Track All Markets

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

Apr 6, 2026 Yahoo Finance

Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock

Mar 20, 2026 Stock Titan

Theravance Biopharma (TBPH) CFO receives 37,500-share equity grant in Form 4

Apr 3, 2026 simplywall.st

While shareholders of Theravance Biopharma (NASDAQ:TBPH) are in the black over 1 year, those who bought a week ago aren't so fortunate

Jan 29, 2026 Yahoo Finance

TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study

Mar 4, 2026 Stock Titan

Theravance Biopharma (TBPH) SVP receives 37,500-share equity grant